We are developing safe and effective treatments for opioid use disorder and dependence. AphioTx is interested in working with pharmaceutical companies, governments, nonprofits, and investors to work towards tackling the opioid crisis by addressing use disorders on a global scale
In Canada, opioid-related deaths have increased by 592% over a 17-year period.
In a one-year period, drug overdose deaths increased in the U.S. by 30.8%. Over 63% of those overdoses were opioid related.
The chances of relapse are 91%, which is the highest relapse rate of any other addiction, second only to alcohol.
We are developing safe and effective new therapies to alleviate opioid withdrawal and treat opioid use disorder. Our treatments help people overcome opioid dependence so that they can focus on their road to recovery.
The AphioTx leadership team is a dynamic group of three scientists, a clinical trial neurologist, and business experts passionate about developing life-changing treatments for patients worldwide. We are committed to finding effective solutions to help people overcome their struggles with opioid use disorder.